Aclaris Therapeutics (ACRS) EBITDA Margin Growth (3y) (2020 - 2026)
Aclaris Therapeutics (ACRS) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Aclaris Therapeutics |
580.93 Mn |
580.93 Mn |
1.60 Mn |
6,980.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
6,980.00 |
| Dec 31, 2025 |
-117,845.00 |
| Sep 30, 2025 |
-33,385.00 |
| Jun 30, 2025 |
50,132.00 |
| Mar 31, 2025 |
33,099.00 |
| Dec 31, 2024 |
48,217.00 |
| Sep 30, 2024 |
110,964.00 |
| Jun 30, 2024 |
59,732.00 |
| Mar 31, 2024 |
90,349.00 |
| Dec 31, 2023 |
83,417.00 |
| Sep 30, 2023 |
42,431.00 |
| Jun 30, 2023 |
-105,420.00 |
| Mar 31, 2023 |
727.00 |
| Dec 31, 2022 |
135,490.00 |
| Sep 30, 2022 |
552,284.00 |
| Jun 30, 2022 |
425,603.00 |
| Mar 31, 2022 |
162,809.00 |
| Dec 31, 2021 |
-48,454.00 |
| Sep 30, 2021 |
165,829.00 |
| Jun 30, 2021 |
-15,262.00 |
